XML 15 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,066,947) $ (9,737,181)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 364,765 1,542,338
Change in fair value of warrants (6,698,692)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (222,783) (1,144,221)
Accounts payable 2,813,995 191,686
Accrued expenses (2,223,090) (2,478,935)
Net cash used in operating activities (7,032,752) (11,626,313)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 3,875,000  
Proceeds from exercise of warrants 540,000  
Proceeds from exercise of stock options   7,386
Net cash provided by financing activities 4,415,000 7,386
Net decrease in cash and cash equivalents (2,617,752) (11,618,927)
Cash and cash equivalents, beginning of period 5,754,720 28,377,693
Cash and cash equivalents, end of period $ 3,136,968 $ 16,758,766